Niagen Bioscience (formerly ChromaDex)
Niagen Bioscience (NASDAQ: NAGE), formerly ChromaDex, is a publicly traded bioscience company that pioneered the commercialization of nicotinamide riboside (NR), an NAD+ precursor. Their flagship ingredient Niagen (nicotinamide riboside chloride) is patented, clinically proven to increase cellular NAD+ by up to 150%, and has received FDA NDI notification. The company holds licensed patents from Cornell University, Dartmouth College, and Washington University in St. Louis. Niagen Bioscience also sells Tru Niagen directly to consumers. The company was renamed from ChromaDex to Niagen Bioscience in March 2025. Based in Los Angeles, California.
Los Angeles, California
Directory Listing · Records Reviewed
Public records and independent sources have been reviewed.
What this means →- MOQMOQ (Minimum Order Quantity)The smallest production run a manufacturer will accept for an order.
- Not publicly disclosed
- LEAD TIMELead TimeThe time from order placement to finished product delivery.
- Not publicly disclosed
§1Editorial assessment
Niagen Bioscience (NASDAQ: NAGE), formerly ChromaDex, is a publicly traded bioscience company that pioneered the commercialization of nicotinamide riboside (NR), an NAD+ precursor. Their flagship ingredient Niagen (nicotinamide riboside chloride) is patented, clinically proven to increase cellular NAD+ by up to 150%, and has received FDA NDI notification. The company holds licensed patents from Cornell University, Dartmouth College, and Washington University in St. Louis. Niagen Bioscience also sells Tru Niagen directly to consumers. The company was renamed from ChromaDex to Niagen Bioscience in March 2025. Based in Los Angeles, California.
§2Six-gate readout
Six gates we apply before any name appears in the directory. Each gate is auto-derived from public evidence on this profile.
§3Inspection history
§4Certifications
No certifications on record.
§5Capability matrix
- PRODUCT TYPES
- Nicotinamide Riboside (Niagen) · NAD+ Precursor Ingredients
- CAPABILITIES
- Patented Branded Ingredient (Niagen NR) · Clinical Research Program · NDI-Notified Ingredient · Licensed University Patents · B2B Ingredient Supply · Consumer Brand (Tru Niagen)
§6Sources
- Niagen Bioscience (ChromaDex) - Official Website(2026-03-26)
- Niagen Bioscience - Wikipedia(2026-03-26)
- NutraIngredients - ChromaDex NDI for Niagen(2026-03-26)
Dietary supplement manufacturers must comply with 21 CFR Part 111 (Current Good Manufacturing Practice for dietary supplements). This includes requirements for personnel, facilities, equipment, production, laboratory operations, and record-keeping.
Disclosures
- No material connection exists between Inventory Ready and this company
- Niagen Bioscience is publicly traded (NASDAQ: NAGE)
- Company was formerly known as ChromaDex; renamed March 2025
For the gate-by-gate readout that produces this vendor's score, see our six-gate scoring readout. The connection map between Niagen Bioscience (formerly ChromaDex) and other vendors, capabilities, and certifications is in the manufacturer atlas.
Interested in Niagen Bioscience (formerly ChromaDex)?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.